Literature DB >> 6670989

Human adenine phosphoribosyltransferase: characterization from subjects with a deficiency of enzyme activity.

T E O'Toole, J M Wilson, M H Gault, W N Kelley.   

Abstract

Adenine phosphoribosyltransferase (APRT) was characterized with respect to specific activity and immunoreactive protein (CRM) levels in hemolysate from 18 members of an APRT-deficient kindred. In addition, lymphoblastoid cell lines were established from six of these subjects and APRT from these cells was characterized in a similar fashion. Levels of specific activity and CRM in patients homozygous for the deficiency were less than 1% of normal. Heterozygous subjects had higher levels of activity and CRM in lymphoblasts than in erythrocytes and, in all cases, the APRT present was normal in terms of isoelectric point, subunit molecular weight, and heart stability. The higher levels of activity and CRM found in lymphoblasts may be due either to expression of a mutant gene product stabilized in a normal:mutant dimer or to autologous regulation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6670989     DOI: 10.1007/bf00488464

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  16 in total

1.  Child's urinary lithiasis revealing a complete deficit in adenine phosphoribosyl transferase.

Authors:  H Debray; P Cartier; A Temstet; J Cendron
Journal:  Pediatr Res       Date:  1976-08       Impact factor: 3.756

2.  Adenine phosphoribosyltransferase deficiency in man. Report of a second family.

Authors:  I H Fox; J C Meade; W N Kelley
Journal:  Am J Med       Date:  1973-11       Impact factor: 4.965

3.  The genetics of peptidase C in man.

Authors:  S Povey; G Corney; W H Lewis; E B Robson; J M Parrington; H Harris
Journal:  Ann Hum Genet       Date:  1972-04       Impact factor: 1.670

4.  Studies on the quantitative variation of human red cell peptidase A activity.

Authors:  K P Sinha; W H Lewis; G Corney; H Harris
Journal:  Ann Hum Genet       Date:  1970-10       Impact factor: 1.670

5.  Urolithiasis due to 2,8-dihydroxyadenine in an adult.

Authors:  M H Gault; H A Simmonds; W Snedden; D Dow; D N Churchill; H Penney
Journal:  N Engl J Med       Date:  1981-12-24       Impact factor: 91.245

6.  Human hypoxanthine-guanine phosphoribosyltransferase. Evidence for tetrameric structure.

Authors:  J A Holden; W N Kelley
Journal:  J Biol Chem       Date:  1978-06-25       Impact factor: 5.157

7.  Human hypoxanthine-guanine phosphoribosyltransferase. Demonstration of structural variants in lymphoblastoid cells derived from patients with a deficiency of the enzyme.

Authors:  J M Wilson; B W Baugher; P M Mattes; P E Daddona; W N Kelley
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

8.  Human adenine phosphoribosyltransferase. Immunochemical quantitation and protein blot analysis of mutant forms of the enzyme.

Authors:  J M Wilson; P E Daddona; H A Simmonds; K J Van Acker; W N Kelley
Journal:  J Biol Chem       Date:  1982-02-10       Impact factor: 5.157

9.  Complete deficiency of adenine phosphoribosyltransferase: a third case presenting as renal stones in a young child.

Authors:  T M Barratt; H A Simmonds; J S Cameron; C F Potter; G A Rose; D G Arkell; D I Williams
Journal:  Arch Dis Child       Date:  1979-01       Impact factor: 3.791

10.  Human hypoxanthine-guanine phosphoribosyltransferase. Purification and characterization of mutant forms of the enzyme.

Authors:  J M Wilson; B W Baugher; L Landa; W N Kelley
Journal:  J Biol Chem       Date:  1981-10-25       Impact factor: 5.157

View more
  2 in total

1.  Human adenine phosphoribosyltransferase. Identification of allelic mutations at the nucleotide level as a cause of complete deficiency of the enzyme.

Authors:  Y Hidaka; T D Palella; T E O'Toole; S A Tarlé; W N Kelley
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

2.  A mutant allele common to the type I adenine phosphoribosyltransferase deficiency in Japanese subjects.

Authors:  A Mimori; Y Hidaka; V C Wu; S A Tarlé; N Kamatani; W N Kelley; T D Pallela
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.